Silencing ALS
with Neil Shneider, M.D., Ph.D.
Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy
Kim-McManus, O., Mignon, L., Douville, J., Pu, H., Parisien, C., Glass, S., Bennett, C.F., Celso, J., Robbins, K., Ung, H., Olson, H., Kingsmore, S.F., Petrou, S., Crooke, S.T., Gleeson, J.G., Berry-Kravis, E. Download PDF
100th Episode: The Personal Rare Disease Journey Behind CNBC Cures
with Becky Quick
Patient Story: Understanding ALS
with Bill O'Sullivan and Neil Shneider, M.D., Ph.D.
n-Lorem Foundation Announces the 50th Nano-rare Patient Receives Personalized ASO Medicine
Physicians collaborating with [...]
Where Emerging FDA Draft Guidance may Lead for Nano-rare Patients
with Andrew Lo, Ph.D.
Miracles of Science: Genomics
Welcome [...]
